BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Bioinformatics Software | QIAGEN Digital Insights - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Bioinformatics Software | QIAGEN Digital Insights
X-ORIGINAL-URL:https://staging.digitalinsights.supremeclients.com
X-WR-CALDESC:Events for Bioinformatics Software | QIAGEN Digital Insights
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/New_York
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20230312T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20231105T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20240310T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20241103T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240502T130000
DTEND;TZID=America/New_York:20240502T143000
DTSTAMP:20260611T041917
CREATED:20240502T035308Z
LAST-MODIFIED:20241024T183038Z
UID:10000756-1714654800-1714660200@staging.digitalinsights.supremeclients.com
SUMMARY:Network construction and customization with QIAGEN Ingenuity Pathway Analysis
DESCRIPTION:Per attendees’ requests from a recent training\, we are hosting this in-depth training focused on effectively constructing a network\, with or without a dataset (RNA-seq\, proteomics\, etc.)\, and easily modifying it – all within Ingenuity Pathway Analysis. \nIn this interactive training\, attendees will learn how to: \n• Construct a network from scratch or open a network/pathway of interest from their analysis or the Ingenuity Knowledge Base\n• Effectively use tools present in the Build and Overlay menus to add molecules (genes/proteins\, chemicals\, metabolites)\, biological processes/diseases of their interest and more\n• Modify the network (e.g.\, to keep only a specific type of relationship like activation\, phosphorylation\, protein-protein binding and more)\n• Perform in silico prediction (e.g.\, if a drug\, siRNA or CRISPR were to reduce the activity of a gene/protein\, how will it impact the remaining genes/proteins/diseases in that network)\n• Export high-resolution graphics or tabular relationships and make the created network usable in future pathway analysis \nAdditional QIAGEN Digital Insights (QDI) scientists will be on the call to answer your questions and help with other concerns\, such as installing the software. \nTo learn more about IPA or request a trial: https://digitalinsights.qiagen.com/products-overview/discovery-insights-portfolio/analysis-and-visualization/qiagen-ipa/?cmpid=CM_QDI_DISC_052024webinars-network
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/network-construction-and-customization-with-qiagen-ingenuity-pathway-analysis-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1233_1_QDI_QDI_IPA_AOP_16x9_63871_Large-1200px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240507T130000
DTEND;TZID=America/New_York:20240507T150000
DTSTAMP:20260611T041917
CREATED:20240416T165254Z
LAST-MODIFIED:20241024T183033Z
UID:10000747-1715086800-1715094000@staging.digitalinsights.supremeclients.com
SUMMARY:New user training: Large dataset analysis and knowledge base queries using QIAGEN Ingenuity Pathway Analysis (IPA)
DESCRIPTION:Join us for a 120-minute training session for new users of QIAGEN IPA. \nIn this training\, you’ll learn how to:\n• Upload your dataset (RNA-seq\, scRNA-seq\, proteomics\, metabolomics and more) and perform interactive core/pathway analysis in IPA\n• Understand the different result types produced (pathways\, key regulators\, impact on biological functions/diseases and more)\n• Compare different experimental conditions (treatments\, time points\, single-cell clusters\, disease types and more) and identify similarities and contrasts\n• Generate a network even without a dataset or experimental design for hypothesis generation \nFor those with IPA license\,\nTo install IPA before or after this training\, please use below installer.\nhttps://qiagen.showpad.com/share/CBv30blCPKFDUYHRWtAvI
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/new-user-training-large-dataset-analysis-and-knowledge-base-queries-using-qiagen-ingenuity-pathway-analysis-ipa-10/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1032_8_QDI_IPAlandExplorer_Gi1170740969_16x9_Medium-720px_52991-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20240513
DTEND;VALUE=DATE:20240516
DTSTAMP:20260611T041917
CREATED:20240418T145504Z
LAST-MODIFIED:20241024T183036Z
UID:10000752-1715558400-1715817599@staging.digitalinsights.supremeclients.com
SUMMARY:International Symposium of Variants 2024
DESCRIPTION:
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/international-symposium-of-variants-2024/
LOCATION:Porto\, Porto\, Portugal
CATEGORIES:Clinical,Event
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240514T130000
DTEND;TZID=America/New_York:20240514T143000
DTSTAMP:20260611T041917
CREATED:20240416T125942Z
LAST-MODIFIED:20241024T183033Z
UID:10000746-1715691600-1715697000@staging.digitalinsights.supremeclients.com
SUMMARY:QIAGEN Biomedical Knowledge Base: data- and analytics-driven drug discovery
DESCRIPTION:Ingenuity pathway analysis (IPA) which is currently cited in tens of thousands of publications and used by large number of biopharmaceuticals is backed by QIAGEN Biomedical Knowledgebase. Accordingly\, Biomedical relationships knowledge has more or less become a requirement for innovative data- and analytics-driven drug discovery. It powers biomedical knowledge graph analysis\, artificial intelligence (AI)-driven target identification and many more applications. \nIn this 1hr webinar\, the speaker will introduce Biomedical Knowledgebase and how it allows its users to tackle applications that are not doable by Ingenuity Pathway Analysis graphical user interface or can be done faster and with more flexibility programmatically. The speaker will demonstrate queries such as \n• Quickly find the shortest connections between genes/proteins/metabolites of interest in the context of specific disease through queries\n• Systematically build a network given a short list genes/proteins/metabolites/chemicals\n• Recreate a drug mechanism of action \nNote: Per feedback of registrants\, we may edit above topics as we would like to cover what would be most relevant to you.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/qiagen-biomedical-knowledge-base-data-and-analytics-driven-drug-discovery-2/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1212_9_QDI_QDI_BKB_Original_61828_16x9_62947_Large-1200px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240515T133000
DTEND;TZID=America/New_York:20240515T143000
DTSTAMP:20260611T041917
CREATED:20240508T132337Z
LAST-MODIFIED:20241024T183039Z
UID:10000759-1715779800-1715783400@staging.digitalinsights.supremeclients.com
SUMMARY:Mitigating Variability in Somatic Variant Interpretation with Live Q&A
DESCRIPTION:Next-generation sequencing (NGS) oncology panels are becoming integral in hospital and academic settings to guide patient treatment and enrollment in clinical trials. But as NGS is increasingly used in precision oncology and an unprecedented amount of genomic information is uncovered\, there is an industry-wide issue of standardization: a high degree of variability in variant interpretation currently exists across laboratories. \nInconsistencies in variant interpretation among laboratories can create confusion for clinicians and their patients\, leaving them unable to confidently use genetic information to manage healthcare decisions. In this live panel discussion\, experts in NGS testing and clinical informatics explore the issues surrounding the standardization of variant interpretation and consider how interpretation guidelines and clinical decision support (CDS) software can help to mitigate variability between laboratories. \nTopics of discussion will include: \n• Findings of a peer-reviewed study comparing the accuracy and consistency of variant assessments from commercial CDS software to the internal variant interpretation methods of eight laboratories. \n• Causes of inter-laboratory inconsistency in variant interpretation and how to mitigate variability. \n• The benefits of having an up-to-date\, high-quality knowledge base to produce consistent\, evidence-based clinical classifications.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/mitigating-variability-in-somatic-variant-interpretation-with-live-qa/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Clinical,Event
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1327_8_QDI_QCI_Hereditary_Gi1346512014.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240516T130000
DTEND;TZID=America/New_York:20240516T140000
DTSTAMP:20260611T041917
CREATED:20240502T035919Z
LAST-MODIFIED:20241024T183038Z
UID:10000757-1715864400-1715868000@staging.digitalinsights.supremeclients.com
SUMMARY:Leveraging the power of API-based omics (RNA-seq\, proteomics and more) queries for discovery
DESCRIPTION:There is a strong interest in the scientific community to use public (GEO\, SRA\, TCGA\, LINCS\, etc.) omics (RNA-seq\, scRNA-seq\, microarray\, proteomics\, etc.) data for a variety of discoveries. This webinar\, aimed at data scientists\, bioinformaticians and similar roles in biopharma and academia\, explores a comprehensive way of accessing and analyzing high-quality\, expertly curated omics data via the QIAGEN OmicSoft APIs. These OmicSoft APIs provide a powerful and flexible platform for discovering\, retrieving\, filtering\, analyzing and visualizing multi-omic data. You can learn how to access the OmicSoft APIs and programmatically leverage extensive metadata to perform custom analyses and identify targets of interest. \nTopics to be covered in this webinar: \n• Leveraging curated metadata to structure queries (metadata refers to cell type\, tissue\, disease\, drug treatment etc.\, associated with public data)\n• Finding multiple samples with the same metadata and creating cohorts\n• Identifying expression and correlation\n• Performing gene set enrichment analysis\n• Testing cell specificity with custom aggregation \nPlease note that the above agenda may be altered per attendee feedback\, as we wish to cover what is most relevant to you. \nTo learn more about OmicSoft data: https://digitalinsights.qiagen.com/news/blog/discovery/boost-your-agility-and-speed-in-drug-development/?cmpid=CM_QDI_DISC_052024webinars-OPI
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/leveraging-the-power-of-api-based-omics-rna-seq-proteomics-and-more-queries-for-discovery/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1188_7_QDI_QDI_OmicSoft.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240516T133000
DTEND;TZID=America/New_York:20240516T153000
DTSTAMP:20260611T041917
CREATED:20240422T123925Z
LAST-MODIFIED:20241024T183038Z
UID:10000755-1715866200-1715873400@staging.digitalinsights.supremeclients.com
SUMMARY:Clinician’s Roundtable: Interpreting genomic test results for precision oncology
DESCRIPTION:You’re invited to attend the 2024 Clinician’s Roundtable\, a virtual event where medical directors and oncologists will discuss how to better interpret genomic test results to tailor treatment strategies for cancer patients. As the role of the Molecular Tumor Board (MTB) becomes increasingly important in the implementation of evidence-based precision cancer medicine programs\, molecular pathology labs must overcome challenges in genomic test interpretation to ensure maximum clinical utility of molecular profiling results. At this event\, hear from clinicians at leading universities and organizations as they present real-world case studies of how molecular pathology labs can improve test turnaround\, standardize test interpretation\, and deliver comprehensive genomic reports with personalized diagnostic\, prognostic\, and therapeutic information for each patient. \nThe free-to-attend virtual event will consist of four educational parts: \n1.    Case Presentations: Clinicians from Dana Farber Cancer Institute and the National Cancer Institute will present cases of how their labs have overcome challenges in genomic test interpretation. \n2.    Live Q&A Session: Attendees will have the opportunity to ask the clinicians questions about their experiences implementing precision oncology programs at their institutions. \n3.    Solution Showcase: In a brief presentation\, experts from QIAGEN Digital Insights will showcase our leading Sample to Insight solutions for molecular tumor profiling. \n4.    Future Forecast: The event will conclude with a short presentation about how molecular tumor profiling will change in the next five years and how labs can leverage new technologies to improve patient care. \n→ Learn more about the 2024 Clinician’s Roundtable here.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/clinicians-roundtable-interpreting-genomic-test-results-for-precision-oncology/
LOCATION:Virtual Global Event (Times shown in EST)
CATEGORIES:Clinical,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1334_4_QDI_QCI_Precision_Insights.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240521T130000
DTEND;TZID=America/New_York:20240521T140000
DTSTAMP:20260611T041917
CREATED:20240416T165746Z
LAST-MODIFIED:20241024T183033Z
UID:10000748-1716296400-1716300000@staging.digitalinsights.supremeclients.com
SUMMARY:Isolate typing\, strain identification and anti-microbial resistance analyses using CLC Genomics Workbench
DESCRIPTION:QIAGEN CLC Genomics Workbench provides tools and workflows for a broad range of bioinformatics applications\, including microbiome analysis\, isolate characterization through SNP and K-mer trees using NGS data\, and antimicrobial resistance characterization. CLC Genomics Workbench is widely used for analyses of bacterial\, viral and eukaryotic (fungal) genomes and metagenomes. \nTopics covered in this webinar include: \nI. Overview of different tools within MGM application and research areas supported\nII. Focused review of isolate typing and characterization\na. Importing data\nb. Utilization of metadata\nc. Downloading and managing references\ni. Database of Isolates/ Resistances/ MLST\nd. Walk through of Type a Known Species workflow\ni. Review details for each Isolate\ne. Creating SNP profiles to specific reference\nf. Generate a SNP tree for isolate comparison\ng. Export tabular and high-quality graphical outputs in wide range of file formats
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/isolate-typing-strain-identification-and-anti-microbial-resistance-analyses-using-clc-genomics-workbench/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Training
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1109_3_QDI_CLC_Challenger_Gi515772677_16x9_56860_Large-1200px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240522T130000
DTEND;TZID=America/New_York:20240522T143000
DTSTAMP:20260611T041917
CREATED:20240502T040505Z
LAST-MODIFIED:20241024T183039Z
UID:10000758-1716382800-1716388200@staging.digitalinsights.supremeclients.com
SUMMARY:Scale up NGS bioinformatics analysis throughput with CLC Genomics Server and Cloud solutions
DESCRIPTION:More and more biopharma and academic groups are looking to process a large number of samples simultaneously or for a quicker turnaround time. This webinar will introduce a flexible and powerful setup for running your NGS sequence analyses through servers or Amazon Web Services (AWS)\, depending on user preference. We will demonstrate how CLC Genomics Workbench can be used to customize workflows and send analyses for batch execution. We will also highlight analysis automation solutions\, use of third-party dockers\, audit trails and user management – all of which are available with the CLC Genomics Server software. \nYou will learn to:\n• Customize template workflows to meet your NGS analysis requirements\n• Set up a CLC Genomics Cloud environment on AWS\n• Submit workflows to run on internal servers or AWS and retrieve results from these analyses\n• Use third-party dockers and automate workflow execution \nTo learn more:\nCLC Genomics Server: https://digitalinsights.qiagen.com/products-overview/discovery-insights-portfolio/enterprise-ngs-solutions/qiagen-clc-genomics-server/?cmpid=CM_QDI_DISC_052024webinars\nCLC Genomics Cloud Module: https://digitalinsights.qiagen.com/plugins/clc-cloud-module/?cmpid=CM_QDI_DISC_052024webinars
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/scale-up-ngs-bioinformatics-analysis-throughput-with-clc-genomics-server-and-cloud-solutions/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1140_5_QDI_CLC_V22_16x9_Large-1200px_58739.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240523T130000
DTEND;TZID=America/New_York:20240523T143000
DTSTAMP:20260611T041917
CREATED:20240513T160252Z
LAST-MODIFIED:20241024T183042Z
UID:10000760-1716469200-1716474600@staging.digitalinsights.supremeclients.com
SUMMARY:Streamline H5N1 and other microbial samples with CLC Genomics Workbench
DESCRIPTION:In this training\, you will learn how to analyze viral samples using QIAGEN CLC Genomics Workbench. This webinar will focus on bioinformatics workflows and data interpretation using H5N1 as an example\, but similar analysis can be done with other viral and microbial (bacteria\, fungus and more) samples. \nUsing viral samples\, you will learn how to: \n• Utilize molecular biology tools such as primer design\, cloning\, alignment and tree construction and Sanger sequencing analysis\n• Profile the virus present in a sample and automatically generate read mappings\, detect variants\, annotate consensus sequences\, BLAST annotated consensus sequence genes and build phylogenetic trees for top hits and their close relatives\n• Microbial genomics analysis including OTU clustering\, taxonomic profiling and functional analysis\n• Additional topics of interest based on registration feedback \nQIAGEN CLC Genomics Workbench is a user-friendly bioinformatics software solutions for genomics\, transcriptomics\, epigenomics and metagenomics analysis in one program.
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/streamline-h5n1-and-other-microbial-samples-with-clc-genomics-workbench/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_1108_8_QDI_CLC_Challenger_Or54963_16x9_56810_Large-1200px-2.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/New_York:20240528T130000
DTEND;TZID=America/New_York:20240528T143000
DTSTAMP:20260611T041917
CREATED:20240416T170229Z
LAST-MODIFIED:20241024T183034Z
UID:10000749-1716901200-1716906600@staging.digitalinsights.supremeclients.com
SUMMARY:Discovery from public data (GEO\, SRA and more) using Ingenuity Pathway Analysis
DESCRIPTION:Per public demand\, we are hosting a comprehensive training on how to effectively use sample level public data and metadata from sources like GEO\, SRA\, TCGA\, GTEx\, Blueprint\, CCLE and other sources through Ingenuity Pathway Analysis (IPA) and IPA Analysis Match Explorer feature. The trainer will walk through use cases in realms of biomarker discovery\, drug–target investigation\, studying survival in custom patient cohorts\, multi-gene correlation and more. \nNote: The word “condition” below refers to different diseases\, disease subtypes\, treatments\, cell types\, cell lines and more. \nThis training will cover topics like\n• How is a gene of interest expressed across different conditions?\n• Is there a correlation in the expression of two genes or biomarkers of interest for a given condition?\n• For a given condition of interest\, can we derive a list of genes (example genes specific to a disease\, treatment or cell type)?\n• Can we generate custom cohorts of patients (example TP53 wt vs mutant or PDCD1 high vs low expression) and then generate survival curves representing those cohorts? Can we generate p-values to see if there is significant difference?\n• Can we detect expression of a gene in different cell types from single cell data?
URL:https://staging.digitalinsights.supremeclients.com/webinars-and-events/discovery-from-public-data-geo-sra-and-more-using-ingenuity-pathway-analysis/
LOCATION:Virtual - Americas - EST\, United States
CATEGORIES:Discovery,Webinar
ATTACH;FMTTYPE=image/jpeg:https://staging.digitalinsights.supremeclients.com/wp-content/uploads/2024/05/S_9343_QDI_IPA_Gi615617548_V2_16x9_Medium-720px_49299.jpg
END:VEVENT
END:VCALENDAR